Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.000
0.00 (0.00%)
Jun 16, 2025, 4:00 PM - Market closed

Inovio Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts that cover Inovio Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $9.75, which forecasts a 387.5% increase in the stock price over the next year. The lowest target is $3 and the highest is $18.

Price Target: $9.75 (+387.5%)
Analyst Consensus: Buy
Target Low Average Median High
Price $3.00 $9.75 $13 $18
Change +50.00% +387.50% +550.00% +800.00%
* Price targets were last updated on May 14, 2025.

Analyst Ratings

The average analyst rating for Inovio Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 000000
Buy 443332
Hold 222222
Sell 000000
Strong Sell 000000
Total 665554

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Hold
Reiterates
$5
Hold Reiterates $5 +150.00% May 14, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$15$13
Buy Maintains $15$13 +550.00% May 14, 2025
RBC Capital
RBC Capital
Hold
Maintains
$6$5
Hold Maintains $6$5 +150.00% Mar 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$3
Hold Reiterates $3 +50.00% Mar 19, 2025
Citizens Capital Markets
Citizens Capital Markets
Buy
Reiterates
$18
Buy Reiterates $18 +800.00% Mar 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
3.90M
from 217.76K
Increased by 1,691.91%
Revenue Next Year
20.43M
from 3.90M
Increased by 423.63%
EPS This Year
-2.33
from -3.95
EPS Next Year
-1.75
from -2.33
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
7.41M1.77M10.26M832.01K217.76K3.90M20.43M74.03M
Revenue Growth
80.24%-76.05%478.24%-91.89%-73.83%1,691.91%423.63%262.33%
EPS
-12.87-17.45-14.07-6.09-3.95-2.33-1.75-1.10
EPS Growth
--------
Forward PE
--------
No. Analysts
-----775
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 16.0M 43.6M 128.5M
Avg 3.9M 20.4M 74.0M
Low 63,700 9.7M 38.0M

Revenue Growth

Revenue Growth 20252026202720282029
High
7,224.7%
1,017.3%
528.9%
Avg
1,691.9%
423.6%
262.3%
Low
-70.7%
148.6%
86.2%

EPS Forecast

EPS 20252026202720282029
High -1.13 -0.63 -0.17
Avg -2.33 -1.75 -1.10
Low -2.90 -2.80 -2.46

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.